Indianapolis, IN, United States of America

Patric James Hahn



 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1999-2023

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovator Patric James Hahn: Pioneering IDH Inhibitor Research

Introduction

Patric James Hahn, a notable inventor based in Indianapolis, IN, is recognized for his significant contributions to the field of pharmaceutical sciences. With a total of nine patents to his name, he has been instrumental in advancing treatments for cancers associated with mutant IDH1 and IDH2 genes.

Latest Patents

Among his recent innovations, Hahn has developed 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds, which serve as inhibitors for the mutant IDH1 and IDH2. This compound is being explored for its potential in treating cancers related to these genetic mutations, highlighting its importance in modern oncology. The structures and compositions associated with these patents offer hope for more effective cancer therapies.

Career Highlights

Patric James Hahn currently works at Eli Lilly and Company, where he is part of a dynamic team focused on groundbreaking medical research and pharmaceuticals. His dedication and innovation have significantly contributed to Eli Lilly's expanding portfolio of cancer-fighting drugs.

Collaborations

Hahn's work has also been enhanced through collaborations with esteemed colleagues such as Renato Alejandro Bauer and Serge Louis Boulet. Together, they continue to push the boundaries of cancer research, contributing to the scientific community and improving patient outcomes.

Conclusion

Through his inventive spirit and dedication to research, Patric James Hahn stands out as a key figure in the development of novel compounds aimed at combatting cancer. His ongoing work at Eli Lilly and Company reflects a commitment to innovation in health care that promises to make a meaningful impact in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…